Lithium aspartate

Lithium aspartate (C₄H₆LiNO₄) is a salt of aspartic acid and lithium. It is sometimes marketed as a dietary supplement used in small doses to treat certain medical conditions; however, there are no systematic reviews supporting the efficacy, or safety of lithium aspartate and it is not approved by the U.S. Food and Drug Administration (FDA) for the treatment of any medical condition. Published research on lithium aspartate is sparse.^[1][2][3]

Lithium aspartate

Clinical data
AHFS/Drugs.com	Monograph
Routes of administration	Oral
Legal status
Legal status	In general: Over-the-counter (OTC)
Identifiers
CAS Number	70962-88-8 Y
PubChem CID	71587253
ChemSpider	34994320 N
UNII	L2N7Z24B30
CompTox Dashboard (EPA)	DTXSID001319264
Chemical and physical data
Formula	C4H6LiNO4
Molar mass	139.04 g·mol−1
3D model (JSmol)	Interactive image
SMILES [Li+].N[C@@H](CC(O)=O)C([O-])=O
InChI InChI=InChI=1S/C4H7NO4.Li/c5-2(4(8)9)1-3(6)7;/h2H,1,5H2,(H,6,7)(H,8,9);/q;+1/p-1/t2-;/m0./s1 N Key:NFNOWBZQMRFQDG-DKWTVANSSA-M N

Aspartic acid stimulates the NMDA receptor.^[4]

See also

• Aspartic acid
• Lithium (medication)